TickerLeague

Capital Expenditures for Cooper Companies (COO)

According to Cooper Companies's latest reported financial statements, the company's current capital expenditures (TTM) is $375.20M USD. Capital expenditures (CapEx) are cash outlays for property, plant, and equipment and other long-lived productive assets — reported on the cash flow statement under investing activities. CapEx funds future capacity (factories, data centers, software, machinery), so rising spend can signal investment in growth, while heavy CapEx reduces free cash flow available to shareholders. We display CapEx as a positive amount (the absolute cash outflow); compare with revenue to gauge capital intensity and with total assets for the asset-base context.

Headline TTM above sums the four reported quarters through (reported ). Chart and table below cover the full reported history back to .

Currently viewingCapital Expenditures

Latest period

$375.20M

YoY change

-14.0%

5Y CAGR

+3.1%

Peak year (2024)

$421.20M

Cumulative capital expenditures

$4.58B

CapEx history chart for Cooper Companies (COO) from 1989 to 2025

CapEx history table for Cooper Companies (COO) from 1989 to 2025

Fiscal yearPeriod endedReportedCapital ExpendituresYoY
2025$362.40M-14.0%
2024$421.20M+7.3%
2023$392.50M+62.2%
2022$242.00M+12.9%
2021$214.40M-30.9%
2020$310.40M+6.3%
2019$292.10M+50.9%
2018$193.60M+52.2%
2017$127.20M-16.6%
2016$152.60M-37.2%
2015$243.02M+2.1%
2014$238.06M+33.6%
2013$178.13M+78.5%
2012$99.78M-3.7%
2011$103.67M+40.5%
2010$73.76M-21.5%
2009$93.91M-24.8%
2008$124.89M-32.0%
2007$183.63M+18.6%
2006$154.86M+32.3%
2005$117.09M+189.1%
2004$40.51M+19.6%
2003$33.87M+44.5%
2002$23.43M+37.9%
2001$16.99M-56.6%
2000$39.11M+287.2%
1999$10.10M-81.3%
1998$53.90M+591.0%
1997$7.80M+143.8%
1996$3.20M+45.5%
1995$2.20M
1994$0-100.0%
1993$1.70M-54.1%
1992$3.70M+146.7%
1991$1.50M
1989$20.90M

CapEx values are taken from Cooper Companies's reported cash flow statements (10-Q quarterly and 10-K annual filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the date the filing was reported; YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.

Analysis

Cooper Companies (COO) most recent annual capital expenditures stands at $362.40M (2025) – declined 14.0% year-over-year.

Over 2020–2025 (5 years), Cooper Companies capital expenditures expanded at a +3.1% compound annual rate, with the latest reading among the more recent periods of the dataset.

Between 2024 and 2025, Cooper Companies capital expenditures declined 14.0%, falling from $421.20M to $362.40M.

$421.20M stands as the all-time-high annual capital expenditures, posted in 2024, against a low of $0 during 1994.

Cooper Companies (COO) sits 9th of 8 Healthcare peers we track on this metric, against a peer median of $3.87B.

Cooper Companies Capital Expenditures by Year

Cooper Companies Capital Expenditures 2025: $362.40M

Cooper Companies capital expenditures in 2025 was $362.40M, declined 14.0% below 2024.

Cooper Companies Capital Expenditures 2024: $421.20M

Cooper Companies capital expenditures in 2024 was $421.20M, grew 7.3% from 2023. This figure represents the highest annual value in the available history.

Cooper Companies Capital Expenditures 2023: $392.50M

Cooper Companies capital expenditures in 2023 was $392.50M, surged 62.2% from 2022.

Cooper Companies Capital Expenditures 2022: $242.00M

Cooper Companies capital expenditures in 2022 was $242.00M, grew 12.9% from 2021.

Cooper Companies Capital Expenditures 2021: $214.40M

Cooper Companies capital expenditures in 2021 was $214.40M.

See more financial history for Cooper Companies (COO).

Sector peers — CapEx

Companies in the same sector as Cooper Companies, ranked by their latest capital expenditures.

CompanyCapital ExpendituresSector
Novo Nordisk A/S (NVO)$90.11BHealthcare
Eli Lilly and Company (LLY)$7.84BHealthcare
Johnson & Johnson (JNJ)$4.83BHealthcare
Merck & Co., Inc. (MRK)$4.11BHealthcare
UnitedHealth Group Incorporated (UNH)$3.62BHealthcare
AstraZeneca PLC (AZN)$2.81BHealthcare
Amgen Inc. (AMGN)$1.86BHealthcare
AbbVie Inc. (ABBV)$1.21BHealthcare

Frequently asked questions

What is Cooper Companies's capital expenditures?

Latest reported capital expenditures for Cooper Companies (COO) is $375.20M (period ending January 31, 2026).

How has Cooper Companies capital expenditures changed year-over-year?

Cooper Companies (COO) capital expenditures changed -14.0% year-over-year on the latest annual filing.

What is the long-term growth rate of Cooper Companies capital expenditures?

Cooper Companies (COO) capital expenditures compound annual growth rate is +3.1% over the most recent 5 years available.

When did Cooper Companies capital expenditures hit its highest annual value?

Cooper Companies capital expenditures reached its highest annual value of $421.20M in 2024.

What was Cooper Companies capital expenditures in 2024?

Cooper Companies (COO) capital expenditures in 2024 was $421.20M.

What was Cooper Companies capital expenditures in 2025?

Cooper Companies (COO) capital expenditures in 2025 was $362.40M.

Metrics overview

Pick a metric for charts, filings, and peers — each row shows the latest TTM or annual value with year-over-year change.